2012/1 GaBI Journal Table of Contents

Contents

Editor’s Letter

Introduction to the GaBI Journal

Editorial

Generic medicine pricing: on track in Europe?

Commentary

Innovator companies should focus on innovations

Review Article

A review of generic medicine pricing in Europe

Biologicals and biosimilars: a review of the science and its implications

A patient-centred paradigm for the biosimilars market

European payer initiatives to reduce prescribing costs through use of generics

A review of patient perspectives on generics substitution: what are the challenges for optimal drug use

Perspective

Myths, questions, facts about generic drugs in the EU

Generic and therapeutic orphans

Special Report

How matrix models can support generic medicine prescribing

Rhythm

Source URL: https://gabi-journal.net/20121-table-of-contents.html